Why the study?
Does aspirin prevent myocardial and cerebrovascular ischemia in primary and secondary prevention settings?
Population
Patients requiring primary or secondary prevention of myocardial or cerebrovascular ischemia
Design
Review
Authors
Loading...
May support selective aspirin use in CAD prevention; leaves open updated RCTs on net benefit versus bleeding in modern cohorts.
Does aspirin prevent myocardial and cerebrovascular ischemia in primary and secondary prevention settings?
Aspirin is a highly potent agent for the primary and secondary prevention of coronary artery disease, though its use carries risks of gastrointestinal and hemorrhagic complications.
Paulette Mehta (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: